Tenax Therapeutics (TENX) Long-Term Investments (2015 - 2020)

Tenax Therapeutics has reported Long-Term Investments for 5 years, with the latest figure at $10723.0 in Q2 2020.

• Long-Term Investments for Q2 2020 came in at $10723.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was $10723.0 (changed N/A YoY), and the FY2017 annual result was $1.8 million, down 78.93% from the prior year.
• Long-Term Investments fell to $10723.0 in Q2 2020, from $296349.0 in the prior quarter.
• Over five years, Long-Term Investments peaked at $19.6 million in Q2 2016 and troughed at $10723.0 in Q2 2020.
• A 4-year average of $5.5 million and a median of $2.3 million in 2017 frame the typical range for Long-Term Investments.
• The widest annual swing landed in 2016, when Long-Term Investments plunged 52.35%; it then sank 91.07% in 2018.
• A 4-year view of Long-Term Investments shows it stood at $8.6 million in 2016, then slumped by 78.93% to $1.8 million in 2017, then plunged by 83.62% to $296349.0 in 2018, then sank by 96.38% to $10723.0 in 2020.
• Per Business Quant data, the three most recent Long-Term Investments figures were $10723.0 in Q2 2020, $296349.0 in Q3 2018, and $297378.0 in Q2 2018.